Results 221 to 230 of about 169,266 (282)

When Pathways Converge: Iron, Lipid Peroxidation, and α-Synuclein in Ferroptosis-Driven Dopaminergic Neurodegeneration. [PDF]

J Neurochem
Sperlich CL, Stockwell BR, Farina M.
europepmc   +1 more source

Alpha-synuclein as a regulator of synaptic signalling [PDF]

Pelkonen, Anssi
core  

Ketamine induces synaptic and monoaminergic remodeling in human iPSC-derived neurons

Sala C, Pagano J, Mangano E, Eminente S, Marcatili M, Krivosova M, Tritto V, Bordoni R, Boeckers T, Conti L.   +9 more
europepmc   +1 more source

A Narrative Review of Synaptic Transmission and Its Role in Neurological and Psychiatric Disorders: A Molecular Perspective. [PDF]

Cureus
Ahmed N, Rather HJ, Rana A, Vasim KA, Thaker KR, Tripathi D.   +5 more
europepmc   +1 more source

The Double-Edged Sword Effect of the Fibrinolytic System in Alzheimer's Disease. [PDF]

Cell Mol Neurobiol
Tang M, Liang M, Zhang X, Hong C, Ye L.
europepmc   +1 more source

Multiplexed neurochemical monitoring reveals glutamate modulates dopamine neurotransmission in the nucleus accumbens. [PDF]

Neurochem Int
Donarski ED, Connors SS, Venton BJ.
europepmc   +1 more source

Role of alpha-synuclein in the regulation of dopamine neurotransmission in the striatum [PDF]

Chadchankar, Heramb
core  

Piperidinyl-3-phosphinic acids as novel uptake inhibitors of the neurotransmitter γ-aminobutyric acid (GABA)

Bioorganic & Medicinal Chemistry Letters, 1999
Piperidinyl-3-phosphinic acid 2, piperidinyl-3-methylphosphinic acid 3 and N-(4,4-diphenyl-3-butenyl)piperidinyl-3-phosphinic acid 4 have been synthesized as bioisosteres of the corresponding amino carboxylic acids, which are potent and specific GABA-uptake inhibitors.
Jan Kehler, Tine B. Stensbøl, Povl Krogsgaard-Larsen   +2 more
semanticscholar   +4 more sources

Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors

Journal of Neural Transmission, 1985
Fluoxetine administration to rats at a dose of 10 mg/kg i.p. daily up to 12 or 24 days failed to change the concentration-dependent binding of [3H]WB4101, [3H]clonidine and [3H]dihydroalprenolol to alpha 1-, alpha 2- and beta-adrenergic receptors, respectively; [3H]quinuclidinyl benzilate to muscarinic receptors; [3H]pyrilamine to histamine H1 ...
David T. Wong, Leroy R. Reid, Frank P. Bymaster, Penny G. Threlkeld   +3 more
openalex   +3 more sources